Re: U.S. Supreme Court case over pharmaceutical labeling

This reminds me of a similar case involving Wyeth a few years ago  
where poor patient information (side effects not being made clear) let  
to problems.

http://en.wikipedia.org/wiki/Fen-phen
http://www.law.com/jsp/article.jsp?id=1109597691121
http://tinyurl.com/af27fh

Brian

---------------------------------------------

Brian Parkinson
Email:  [email protected]



On 6 Mar 2009, at 12:15 am, Deborah Taylor-Pearce wrote:

> The case was about whether or not an "inadequate" warning label for
> the drug Phenergan -- even though OKed by the U.S. Federal Drug
> Administration -- placed the drug company (Wyeth) at risk for  
> lawsuits.
>
> The issues involved have more to do with U.S. legal matters than with
> medical information design, but still, I thought some of you on this
> list would be interested, since pharmaceutical labeling standards are
> at the core of the legal challenge.

___________________________________________________________________

Use the following address to post a message to all subscribers: 
 [email protected]

To subscribe, unsubscribe or change your options, visit:
 http://list.InformationDesign.org/mailman/listinfo/infodesign-cafe

For all Information Design matters:
 http://InformationDesign.org

Problems? Write to:
 [email protected]
___________________________________________________________________